Teijin Limited

2026/08/21 Updated
Market Cap: $2.1B (¥334.8B)
Stock Price: $10.92 (¥1,736)
Exchange Rate: 1 USD = ¥158.98

Stock Price Chart

2026/08/21 Updated
0.00
PER (Price Earnings Ratio)
vs Industry Avg: -9.6
0.81
PBR (Price to Book Ratio)
vs Industry Avg: -0.5
2.90%
Dividend Yield
vs Industry Avg: -0.05%

Price Trend

2026/08/21 Updated
Short-term
5-Day MA
-0.52%
Near-term
25-Day MA
+1.53%
Mid-term
75-Day MA
+4.49%
Long-term
200-Day MA
+13.09%

Price & Trading Details

2026/08/21 Updated

PRICE

Previous Close ¥1,727
Open ¥1,750
High ¥1,763
Low ¥1,720
Close ¥1,736

TRADING

Volume 503,500
Average Volume 829,269
Turnover ¥9億
Min. Purchase ¥173,550

Analyst Recommendations 5 analysts

Updated 2026/08/01
Strong Buy
0
Buy
0
Hold
4
4
Sell
1
1
Strong Sell
0
Target Price (Mean)
¥1,524
None
¥1,700
High
¥1,570
Median
¥1,250
Low
+13% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Earnings Calendar

Updated 2026/08/01
AUG
04
2026
Next Earnings Release
Q3 FY2026

Recent Earnings

Date EPS Est. EPS Actual Surprise
2024/02/07 ¥34.30 ¥20.75 -39.5%
2023/11/06 ¥31.70 ¥-12.46 -139.3%
2021/02/07 ¥29.20 ¥56.39 +93.1%
2020/11/01 ¥17.20 ¥53.66 +212.0%

Shareholder Composition

Updated 2026/08/01
4.1%
Insider Holdings
60.8%
Institutional
35.2%
Public Float
132
Institutional Holders
Insider Holdings 4.1%
Institutional 60.8%
Public Float 35.2%

Top Mutual Funds / ETFs

Updated 2026/08/01

Major Holders

Updated 2026/08/01
Fund Name Ownership Shares Change
American Century ETF Trust-Avantis International Small Cap Value ETF
2.67%
5.3M +4.63%
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.32%
2.6M 0.00%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.90%
1.8M +2.25%
American Century ETF Trust-Avantis International Equity ETF
0.66%
1.3M +2.87%
iShares Trust-iShares Core MSCI EAFE ETF
0.59%
1.2M 0.00%
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.
0.50%
986.6K 0.00%
Institution Ownership Shares Change
Legato Capital Management LLC
0.02%
30.1K +14.02%

Dividend History

Updated 2026/08/23
-%
Dividend Yield
¥25
Annual Dividend
-50.0%
YoY Growth
-%
Payout Ratio
Year Dividend Change
2026 ¥25 -50.0%
2025 ¥50 +25.0%
2024 ¥40 +45.5%
2023 ¥28 -50.0%
2022 ¥55 -

Financial Performance

2026/08/23 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥926,054M ¥1,018,751M ¥960,459M ¥1,005,471M
Gross Profit ¥271,022M ¥248,136M ¥210,644M ¥191,452M
Operating Income ¥44,209M ¥12,863M -¥4,912M -¥71,828M
Pretax Income ¥47,317M ¥5,594M ¥13,276M -¥66,660M
Net Income ¥23,158M -¥17,695M -¥11,712M ¥28,347M
EPS ¥115.72 -¥92.04 ¥55.00 -
Operating Margin 4.77% 1.26% -0.51% -7.14%
Balance Sheet
Total Assets ¥1,207,583M ¥1,228,229M ¥1,226,616M ¥1,061,272M
Total Equity ¥440,384M ¥390,899M ¥409,507M ¥431,377M
Total Liabilities ¥767,199M ¥837,330M ¥817,109M ¥629,895M
Cash ¥134,480M ¥140,307M ¥123,212M ¥107,538M
Interest-bearing Debt ¥483,644M ¥547,046M ¥516,937M ¥387,127M
Equity Ratio 36.47% 31.83% 33.39% 40.65%
D/E Ratio 1.10 1.40 1.26 0.90
Cash Flow
Operating CF ¥89,656M ¥55,086M ¥80,595M ¥69,843M
Investing CF -¥198,375M -¥52,427M -¥56,561M ¥52,517M
Financing CF ¥71,113M ¥7,180M -¥43,793M -¥134,459M
Free CF -¥110,820M -¥2,650M ¥5,045M ¥8,417M
Efficiency
ROE 5.26% -4.53% -2.86% 6.57%
ROA 1.92% -1.44% -0.95% 2.67%

Latest IR Information

Company Information

English Name Teijin Limited
Japanese Name 帝人(株)
Stock Code 3401.T (JPX)
Sector / Industry Industrials / Conglomerates
Employees 15,689

About

Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses in Japan and internationally. The company provides aramid fibers; glass and carbon fibers, composite materials, infusion resins, adhesives, fillers and resin films, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films. It also offers PC resins, polyphenylene sulfide resins, molded parts, flame retardant, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. In addition, the company provides pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, continuous positive airway pressure, respiratory support, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system businesses. Further, the company provides implantable medical devices and regenerative medical products. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline. Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.

Data provided by Yahoo Finance